Association Between Thyroid Hormone Levels and Advanced Liver Fibrosis in Patients with Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease

References

• Mantovani A , Byrne CD , Bonora E , Targher G . Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis. Diabetes Care . 2018;41(2):372–382. doi:10.2337/dc17-1902 29358469
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Koenig AB , Abdelatif D , Fazel Y , Henry L , Wymer M . Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology . 2016;64(1):73–84. doi:10.1002/hep.28431 26707365
   PubMed Web of Science ®Google Scholar
• Younossi ZM , Golabi P , de Avila L , et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol . 2019;71(4):793–801. doi:10.1016/j.jhep.2019.06.021 31279902
   PubMed Web of Science ®Google Scholar
• Dulai PS , Singh S , Patel J , et al. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: systematic review and meta-analysis. Hepatology . 2017;65(5):1557–1565. doi:10.1002/hep.29085 28130788
   PubMed Web of Science ®Google Scholar
• Taylor RS , Taylor RJ , Bayliss S , et al. Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Gastroenterology . 2020;158(6):1611–1625. doi:10.1053/j.gastro.2020.01.043 32027911
   PubMed Web of Science ®Google Scholar
• Leite NC , Villela-Nogueira CA , Pannain VL , et al. Histopathological stages of nonalcoholic fatty liver disease in type 2 diabetes: prevalences and correlated factors. Liver Int . 2011;31(5):700–706. doi:10.1111/j.1478-3231.2011.02482.x 21457442
   PubMed Web of Science ®Google Scholar
• Loomba R , Abraham M , Unalp A , et al. Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology . 2012;56(3):943–951. doi:10.1002/hep.25772 22505194
   PubMed Web of Science ®Google Scholar
• Chalasani N , Younossi Z , Lavine JE , et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology . 2018;67(1):328–357.28714183
   PubMed Web of Science ®Google Scholar
• Mantovani A , Nascimbeni F , Lonardo A , et al. Association between primary hypothyroidism and nonalcoholic fatty liver disease: a systematic review and meta-analysis. Thyroid . 2018;28(10):1270–1284. doi:10.1089/thy.2018.0257 30084737
   PubMed Web of Science ®Google Scholar
• Qiu S , Cao P , Guo Y , Lu H , Hu Y . Exploring the causality between hypothyroidism and non-alcoholic fatty liver: a Mendelian Randomization Study. Front Cell Dev Biol . 2021;9:643582. doi:10.3389/fcell.2021.643582 33791302
   PubMed Web of Science ®Google Scholar
• Manka P , Bechmann L , Best J , et al. Low free triiodothyronine is associated with advanced fibrosis in patients at high risk for nonalcoholic steatohepatitis. Dig Dis Sci . 2019;64(8):2351–2358. doi:10.1007/s10620-019-05687-3 31155687
   PubMed Web of Science ®Google Scholar
• Kim D , Yoo ER , Li AA , et al. Low-normal thyroid function is associated with advanced fibrosis among adults in the United States. Clin Gastroenterol Hepatol . 2019;17(11):2379–2381. doi:10.1016/j.cgh.2018.11.024 30458247
   PubMed Web of Science ®Google Scholar
• Jian-gao F . Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition. Chin j Hepatol . 2010;18(3):163–166.
   PubMedGoogle Scholar
• Paul A , Jason MH , Giulio M , et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology . 2007;45(4).
   Web of Science ®Google Scholar
• Rinella ME . Nonalcoholic fatty liver disease: a systematic review. JAMA . 2015;313(22):2263–2273. doi:10.1001/jama.2015.5370 26057287
   PubMed Web of Science ®Google Scholar
• Bril F , Cusi K . Management of nonalcoholic fatty liver disease in patients with type 2 diabetes: a call to action. Diabetes Care . 2017;40(3):419–430. doi:10.2337/dc16-1787 28223446
   PubMed Web of Science ®Google Scholar
• Lee YH , Cho Y , Lee BW , et al. Nonalcoholic fatty liver disease in diabetes. part i: epidemiology and diagnosis. Diabetes Metab J . 2019;43(1):31–45. doi:10.4093/dmj.2019.0011 30793550
   PubMed Web of Science ®Google Scholar
• Marra F , Svegliati-Baroni G . Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol . 2018;68(2):280–295. doi:10.1016/j.jhep.2017.11.014 29154964
   PubMed Web of Science ®Google Scholar
• Ipsen DH , Lykkesfeldt J , Tveden-Nyborg P . Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci . 2018;75(18):3313–3327.29936596
   PubMed Web of Science ®Google Scholar
• Mullur R , Liu YY , Brent GA . Thyroid hormone regulation of metabolism. Physiol Rev . 2014;94(2):355–382. doi:10.1152/physrev.00030.2013 24692351
   PubMed Web of Science ®Google Scholar
• Sinha RA , Bruinstroop E , Singh BK , Yen PM . Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists. Thyroid . 2019;29(9):1173–1191. doi:10.1089/thy.2018.0664 31389309
   PubMed Web of Science ®Google Scholar
• Sinha RA , Singh BK , Yen PM . Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol . 2018;14(5):259–269. doi:10.1038/nrendo.2018.10 29472712
   PubMed Web of Science ®Google Scholar
• Bano A , Chaker L , Plompen EP , et al. Thyroid function and the risk of nonalcoholic fatty liver disease: the Rotterdam Study. J Clin Endocrinol Metab . 2016;101(8):3204–3211. doi:10.1210/jc.2016-1300 27270473
   PubMed Web of Science ®Google Scholar
• Pascual A , Aranda A . Thyroid hormone receptors, cell growth and differentiation. Biochim Biophys Acta . 2013;1830(7):3908–3916. doi:10.1016/j.bbagen.2012.03.012 22484490
   PubMed Web of Science ®Google Scholar
• Perra A , Simbula G , Simbula M , et al. Thyroid hormone (T3) and TRbeta agonist GC-1 inhibit/reverse nonalcoholic fatty liver in rats. FASEB J . 2008;22(8):2981–2989. doi:10.1096/fj.08-108464 18434432
   PubMed Web of Science ®Google Scholar
• Sinha RA , Yen PM . Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD. Cell Biosci . 2016;6:46. doi:10.1186/s13578-016-0113-7 27437098
   PubMed Web of Science ®Google Scholar
• Alonso-Merino E , Martin OR , Ruiz-Llorente L , et al. Thyroid hormones inhibit TGF-beta signaling and attenuate fibrotic responses. Proc Natl Acad Sci U S A . 2016;113(24):E3451–E3460. doi:10.1073/pnas.1506113113 27247403
   PubMed Web of Science ®Google Scholar
• Iannucci LF , Cioffi F , Senese R , et al. Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet. Sci Rep . 2017;7(1):2023. doi:10.1038/s41598-017-02205-1 28515456
   PubMed Web of Science ®Google Scholar
• Harrison SA , Bashir MR , Guy CD , et al. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, Phase 2 trial. Lancet . 2019;394(10213):2012–2024. doi:10.1016/S0140-6736(19)32517-6 31727409
   PubMed Web of Science ®Google Scholar
• Chaurasia B , Summers SA . Ceramides - Lipotoxic Inducers of Metabolic Disorders. Trends Endocrinol Metab . 2015;26(10):538–550. doi:10.1016/j.tem.2015.07.006 26412155
   PubMed Web of Science ®Google Scholar
• Spencer CA , Hollowell JG , Kazarosyan M , Braverman LE . National Health and Nutrition Examination Survey III thyroid-stimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J Clin Endocrinol Metab . 2007;92(11):4236–4240. doi:10.1210/jc.2007-0287 17684054
   PubMed Web of Science ®Google Scholar
• Pan YW , Tsai MC , Yang YJ , Chen MY , Chen SY , Chou YY . The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. Kaohsiung J Med Sci . 2019;35(12):778–786. doi:10.1002/kjm2.12118 31400075
   PubMed Web of Science ®Google Scholar
• Chen P , Hou X , Wei L , et al. Free triiodothyronine is associated with the occurrence and remission of nonalcoholic fatty liver disease in euthyroid women. Eur J Clin Invest . 2019;49(4):e13070. doi:10.1111/eci.13070 30636282
   PubMed Web of Science ®Google Scholar